This inventor holds 1 USPTO granted patent. Top assignees: Oregon Health & Science University, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2019.
Company Filing History:


Years Active: 2019
Title: Slim Fourati: Innovator in HIV Research
Introduction
Slim Fourati is a notable inventor based in Cleveland, OH (US). He has made significant contributions to the field of HIV research, particularly in developing methods to improve vaccine efficacy. His innovative approach focuses on utilizing Ras pathways as markers of protection against HIV.
Latest Patents
Slim Fourati holds a patent titled "Ras pathways as markers of protection against HIV and methods to improve vaccine efficacy." This patent discloses compositions that include a therapeutically effective amount of an HIV immunogen combined with an agent that stimulates the Ras pathway, excluding aluminum salts. The patent also outlines methods for inducing an immune response to HIV and for inhibiting or treating HIV infection in subjects. Furthermore, it describes techniques for determining the potential of an immunogenic composition to induce a protective response by assessing its impact on the Ras signaling pathway.
Career Highlights
Throughout his career, Slim Fourati has worked with reputable institutions, including Oregon Health & Science University and the United States Department of Health and Human Services. His work has been pivotal in advancing the understanding of HIV and developing potential therapeutic strategies.
Collaborations
Slim Fourati has collaborated with notable colleagues, including Namal Malimbada Liyanage and Luca Schifanella. These partnerships have contributed to the depth and breadth of his research in the field of HIV.
Conclusion
Slim Fourati's innovative work in HIV research and his patent contributions highlight his commitment to improving vaccine efficacy and understanding immune responses. His efforts continue to pave the way for advancements in the fight against HIV.